Literature DB >> 9694750

Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.

.   

Abstract

OBJECTIVE: To evaluate the impact of the revised diagnostic criteria for diabetes mellitus adopted by the American Diabetes Association on prevalence of diabetes and on classification of patients. For epidemiological purposes the American criteria use a fasting plasma glucose concentration >=7.0 mmol/l in contrast with the current World Health Organisation criteria of 2 hour glucose concentration >=11.1 mmol/l.
DESIGN: Data were collected from 13 populations and three occupational based studies from eight European countries. All studies used a 75 g oral glucose tolerance test to measure fasting and 2 hour glucose concentrations.
SUBJECTS: 17 881 men; 8309 women; age range 17-92 years. MAIN OUTCOME MEASURES: Classification of diabetes according to both sets of criteria.
RESULTS: The application of the American criteria on European populations induced changes in prevalence of diabetes ranging from a reduction of 4.0% to an increase of 13.2%. A total of 1517 previously undiagnosed individuals had diabetes according to either the WHO or the American criteria. Among 1044 with diabetes according to American criteria, only 45% had 2 hour values fulfilling the WHO criteria. The risk of disagreement of classification decreased with increasing body mass index (P<0.00001) and increasing age (P<0.0001); the impact of sex was not significant (P=0.08).
CONCLUSIONS: This shift in strategy from using 2 hour to fasting plasma glucose will cause an increase in the prevalence of diabetes in some European populations. A high degree of disagreement in the classification was observed between the two recommendations. Prospective data are needed to evaluate whether the WHO or the American criteria best identify individuals at risk of developing microvascular complications and cardiovascular disease. Wider implementation of revised diagnostic criteria should await prospective data.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694750      PMCID: PMC28629          DOI: 10.1136/bmj.317.7155.371

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  28 in total

1.  Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.

Authors:  M M Engelgau; T J Thompson; W H Herman; J P Boyle; R E Aubert; S J Kenny; A Badran; E S Sous; M A Ali
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

2.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

3.  Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases.

Authors:  O Lindberg; R S Tilvis; T E Stranberg; J Valvanne; S Sairanen; C Ehnholm; J Tuomilehto
Journal:  J Am Geriatr Soc       Date:  1997-04       Impact factor: 5.562

4.  Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK.

Authors:  N Unwin; J Harland; M White; R Bhopal; P Winocour; P Stephenson; W Watson; C Turner; K G Alberti
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

5.  Glucose tolerance and coronary heart disease: Helsinki policemen study.

Authors:  K Pyörälä; E Savolainen; E Lehtovirta; S Punsar; P Siltanen
Journal:  J Chronic Dis       Date:  1979

6.  WHO Expert Committee on Diabetes Mellitus: second report.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1980

7.  Who is being screened for cervical cancer?

Authors:  J C Kleinman; A Kopstein
Journal:  Am J Public Health       Date:  1981-01       Impact factor: 9.308

8.  Metabolic syndrome' in a middle-aged Finnish population.

Authors:  M J Vanhala; E A Kumpusalo; T K Pitkäjärvi; J K Takala
Journal:  J Cardiovasc Risk       Date:  1997-08

9.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  84 in total

1.  UK's diagnostic criteria for diabetes are different from US's.

Authors:  E S Kilpatrick
Journal:  BMJ       Date:  1999-10-02

2.  New diagnostic criteria for diabetes mellitus. New criteria result in fewer cases in older adults.

Authors:  H E Resnick; T B Harris
Journal:  BMJ       Date:  1999-02-20

Review 3.  [Screening and diagnosis criteria for diabetes mellitus].

Authors:  M Birules Pons; I Fernández Fernández
Journal:  Aten Primaria       Date:  2003-03-31       Impact factor: 1.137

Review 4.  Prandial glucose regulation in the glucose triad: emerging evidence and insights.

Authors:  Paul Beisswenger; Robert J Heine; Lawrence A Leiter; Alan Moses; Jaakko Tuomilehto
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

Review 5.  The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.

Authors:  Andrew W Lyon; Erik T Larsen; Alun L Edwards
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

Review 6.  Have we got the new diagnostic criteria for diabetes and impaired glucose states right? Almost.

Authors:  K George M M Alberti
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 7.  Best practice in primary care pathology: review 10.

Authors:  W S A Smellie; N Shaw; R Bowley; M F Stewart; A M Kelly; P J Twomey; P R Chadwick; J B Houghton; J P Ng; A J McCulloch
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

8.  Defining a comprehensive verotype using electronic health records for personalized medicine.

Authors:  Mary Regina Boland; George Hripcsak; Yufeng Shen; Wendy K Chung; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2013-09-03       Impact factor: 4.497

9.  Diagnosing diabetes--time for a change?

Authors:  K Borch-Johnsen; S Colagiuri
Journal:  Diabetologia       Date:  2009-09-08       Impact factor: 10.122

10.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.